Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paramita Chakraborty

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Trends in Immunology|February 17, 2020
CD38: Modulating Histone Methyltransferase EZH2 Activity in SLEParamita Chakraborty, Shikhar Mehrotra
Cancer Research|October 13, 2023
Fatty Acids Invigorate Tumor-Resident Memory T CellsParamita Chakraborty, Stephanie Mills, Shikhar Mehrotra
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 19, 2013
The role of a Schiff base scaffold, N-(2-hydroxy acetophenone) glycinate-in overcoming multidrug resistance in cancerAvishek Ganguly, Paramita Chakraborty, Kaushik Banerjee, et al.
Journal of Immunology Research and Therapy|October 25, 2016
Dynamic Metabolism in Immune ResponseMazen Al-Hommrani, Paramita Chakraborty, Shilpak Chatterjee, et al.
Cells|April 27, 2026
The Dual Faces of S1P: Orchestrating Immune Responses in Health and DiseaseStephanie A Mills, David Barr, Shikhar Mehrotra, et al.
Cells|February 25, 2022
New Developments in T Cell Immunometabolism and Implications for Cancer ImmunotherapyNathaniel Oberholtzer, Kristen M Quinn, Paramita Chakraborty, et al.
Advances in Cancer Research|July 28, 2024
Role of antioxidants in modulating anti-tumor T cell immune resposneNathaniel Oberholtzer, Stephanie Mills, Shubham Mehta, et al.
Advanced Drug Delivery Reviews|July 11, 2022
HuR as a molecular target for cancer therapeutics and immune-related disordersMrinmoyee Majumder, Paramita Chakraborty, Sarumathi Mohan, et al.
Immunobiology|September 22, 2012
Myeloid derived suppressor cells (MDSCs) can induce the generation of Th17 response from naïve CD4+ T cellsShilpak Chatterjee, Satyajit Das, Paramita Chakraborty, et al.
Immunopharmacology and Immunotoxicology|March 12, 2014
A copper chelate selectively triggers apoptosis in myeloid-derived suppressor cells in a drug-resistant tumor model and enhances antitumor immune responseParamita Chakraborty, Satyajit Das, Kaushik Banerjee, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Trends in Immunology|February 17, 2020
CD38: Modulating Histone Methyltransferase EZH2 Activity in SLEParamita Chakraborty, Shikhar Mehrotra
Cancer Research|October 13, 2023
Fatty Acids Invigorate Tumor-Resident Memory T CellsParamita Chakraborty, Stephanie Mills, Shikhar Mehrotra
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 19, 2013
The role of a Schiff base scaffold, N-(2-hydroxy acetophenone) glycinate-in overcoming multidrug resistance in cancerAvishek Ganguly, Paramita Chakraborty, Kaushik Banerjee, et al.
Journal of Immunology Research and Therapy|October 25, 2016
Dynamic Metabolism in Immune ResponseMazen Al-Hommrani, Paramita Chakraborty, Shilpak Chatterjee, et al.
Cells|April 27, 2026
The Dual Faces of S1P: Orchestrating Immune Responses in Health and DiseaseStephanie A Mills, David Barr, Shikhar Mehrotra, et al.
Cells|February 25, 2022
New Developments in T Cell Immunometabolism and Implications for Cancer ImmunotherapyNathaniel Oberholtzer, Kristen M Quinn, Paramita Chakraborty, et al.
Advances in Cancer Research|July 28, 2024
Role of antioxidants in modulating anti-tumor T cell immune resposneNathaniel Oberholtzer, Stephanie Mills, Shubham Mehta, et al.
Advanced Drug Delivery Reviews|July 11, 2022
HuR as a molecular target for cancer therapeutics and immune-related disordersMrinmoyee Majumder, Paramita Chakraborty, Sarumathi Mohan, et al.
Immunobiology|September 22, 2012
Myeloid derived suppressor cells (MDSCs) can induce the generation of Th17 response from naïve CD4+ T cellsShilpak Chatterjee, Satyajit Das, Paramita Chakraborty, et al.
Immunopharmacology and Immunotoxicology|March 12, 2014
A copper chelate selectively triggers apoptosis in myeloid-derived suppressor cells in a drug-resistant tumor model and enhances antitumor immune responseParamita Chakraborty, Satyajit Das, Kaushik Banerjee, et al.
Pageof 6